Spatiotemporal changes of tissue glycans depending on localization in cardiac aging.
Regen Ther
; 22: 68-78, 2023 Mar.
Article
en En
| MEDLINE
| ID: mdl-36712959
ABSTRACT
Heart failure is caused by various factors, making the underlying pathogenic mechanisms difficult to identify. Since cardiovascular disease tends to worsen over time, early diagnosis is key for treatment. In addition, understanding the qualitative changes in the heart associated with aging, where information on the direct influences of aging on cardiovascular disease is limited, would also be useful for treatment and diagnosis. To fill these research gaps, the focus of our study was to detect the structural and functional molecular changes associated with the heart over time, with a focus on glycans, which reflect the type and state of cells. METHODS:
We investigated glycan localization in the cardiac tissue of normal mice and their alterations during aging, using evanescent-field fluorescence-assisted lectin microarray, a technique based on lectin-glycan interaction, and lectin staining.RESULTS:
The glycan profiles in the left ventricle showed differences between the luminal side (medial) and wall side (lateral) regions. The medial region was characterized by the presence of sialic acid residues. Moreover, age-related changes in glycan profiles were observed at a younger age in the medial region. The difference in the age-related decrease in the level of α-galactose stained with Griffonia simplicifolia lectin-IB4 in different regions of the left ventricle suggests spatiotemporal changes in the number of microvessels.CONCLUSIONS:
The glycan profile, which retains diverse glycan structures, is supported by many cell populations, and maintains cardiac function. With further research, glycan localization and changes have the potential to be developed as a marker of the signs of heart failure.
ACG, Agrocybe cylindracea galectin; Aging; BPL, Bauhinia purpurea alba lectin; Calsepa, Calystegia sepium agglutinin; Cardiac tissue; ConA, Canavalia ensiformis lectin; DAPI, 4',6-diamidino-2-phenylindole; DBA, Dolichos biflorus agglutinin; ECA, Erythrina cristagalli agglutinin; ECM, extracellular matrices; EMT, endothelial-to-mesenchymal transition; FITC, fluorescein isothiocyanate; GSL-I, Griffonia simplicifolia lectin I; Gal, galactose; GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine; Glycan profile; HE, hematoxylin-eosin; LEL, Lycopersicon esculentum lectin; LTL, Lotus tetragonolobus lectin; Lectin microarray; MAH, Maackia amurensis hemagglutinin; MAL-I, Maackia amurensis lectin I; Man, mannose; Microvessels; NPA, Narcissus pseudonarcissus agglutinin; PBS, phosphate-buffered saline; PCA, principal component analysis; PHA-L, Phaseolus vulgaris leucoagglutinin; PNA, Arachis hypogaea agglutinin; RCA120, Ricinus communis agglutinin I; SBA, Glycine max agglutinin; SNA, Sambucus nigra agglutinin; SSA, Sambucus sieboldiana agglutinin; STL, Solanum tuberosum lectin; TJA-I, Trichosanthes japonica agglutinin I; UDA, Urtica dioica; VVA, Vicia villosa agglutinin; WFA, Wisteria floribunda agglutinin; WGA, Triticum vulgaris agglutinin (wheat germ agglutinin); α-SMA, alpha smooth muscle actin
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Qualitative_research
/
Screening_studies
Idioma:
En
Revista:
Regen Ther
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón